Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	59
Total, all-cause mortality	HB/APAP	0	60
Total, all-cause mortality	VX-548: Low Dose	0	33
Total, all-cause mortality	VX-548: Mid Dose	0	62
Total, all-cause mortality	VX-548: High Dose	0	60
Total, other adverse events	Placebo	12	59
Total, other adverse events	HB/APAP	13	60
Total, other adverse events	VX-548: Low Dose	2	33
Total, other adverse events	VX-548: Mid Dose	7	62
Total, other adverse events	VX-548: High Dose	9	60
Total, serious adverse events	Placebo	0	59
Total, serious adverse events	HB/APAP	0	60
Total, serious adverse events	VX-548: Low Dose	0	33
Total, serious adverse events	VX-548: Mid Dose	0	62
Total, serious adverse events	VX-548: High Dose	0	60

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04977336/event-totals